Wal-Mart Adds Prescription Women's Health Medications To Discount Drug Program
Main Category: Women's Health / GynecologyAlso Included In: Pharmacy / Pharmacist
Article Date: 08 May 2008 - 7:00 PDT
| Patient / Public: | ![]() |
4.33 (3 votes) |
| Health Professional: | ![]() |
5 (2 votes) |
| Article Opinions: | 0 posts |
Wal-Mart Stores on Monday announced that it is adding several women's health-related medications to its discounted prescription drug program, the Wall Street Journal reports.
Wal-Mart pharmacies will provide $9 generic prescriptions for up to 30-day supplies of several drugs that treat breast cancer, hormone deficiency, menopause and osteoporosis (Zimmerman, Wall Street Journal, 5/6). Some of the drugs that will be sold for $9 include: the breast cancer drug tamoxifen; alendronate, the generic version of the osteoporosis medication Fosamax; and a combination of estrogen/methyltestosterone tablets for menopause and hormone deficiency.
In addition, Wal-Mart plans to lower the prices of monthly supplies of more than 1,000 over-the-counter drugs, including its own brand of prenatal vitamins, to $4 or less. It also will offer 90-day supplies of more than 300 generic medicines for $10. Target late Monday said it will match the major elements of Wal-Mart's program, adding that more details about which drugs it will discount will be released soon (AP/New York Times, 5/6).
Wal-Mart's discount program, which started in September 2006, also provides 30-day supplies of several family planning drugs, including generic versions of Ortho Cyclen and Ortho Tri-Cyclen for $9. Kroger launched a similar discount program in March (Daily Women's Health Policy Report, 2/7).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2008 The Advisory Board Company. All rights reserved.
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |





